Table 1.

Strategies and Population Coverage^*

Strategy	Vaccine Component	Antiviral Component	Non-pharmaceutical Intervention Component†
Stockpiled strategy	90μg non-adjuvanted vaccine‡ to 7% 3.8μg adjuvanted vaccine to 1%	5-day treatment§ to 28% 40-day prophylaxis** to 5%	25% reduction in contacts
Expanded antiviral prophylaxis	90μg non-adjuvanted vaccine to 7% 3.8μg adjuvanted vaccine to 1%	5-day treatment to 28% 40-day prophylaxis to 40%	25% reduction in contacts
Expanded adjuvanted vaccination	3.8μg adjuvanted vaccine to 40%	5-day treatment to 28% 40-day prophylaxis to 5%	25% reduction in contacts

^*Strategies are layered on stockpiled strategy. Components of strategies which differ from stockpiled strategy are denoted in italics.

^†Includes personal protective equipment, cough etiquette, hand-washing, alcohol hand gels, school and workplace closures

^‡All two-dose sequences of vaccine consist of a primer and booster dose received three weeks apart as described in stockpiled strategy.

^§Oseltamivir (75mg orally) or zanamivir (10mg inhaled) twice daily as described in stockpiled strategy.

^**Oseltamivir (75mg orally) or zanamivir (10mg inhaled) once daily as described in stockpiled strategy.